MAS Equity Partners

Day-to-day investment decisions are led by Managing Partner & CIO Patricio D'Apice alongside Managing Partner & CEO Héctor Cateriano. The firm maintains a fund-specific investment committee: Hubertus van der Vaart and Julio Manuel Ayerbe have served on the committee for Fondos I, II, and III, while D'Apice and Hernán Pérez De Brigard joined for Fondo III. Cateriano has been on the committee for all three fund vintages.

The firm does not publicly detail its origination channels, but its positioning as the first-mover growth capital investor in the Colombian mid-market — operating for over 16 years — suggests a network-driven model. The principals' long tenure and ColCapital industry recognitions, including multiple 'Most Successful Private Equity Investment' awards, indicate relationships with local entrepreneurs, corporate governance networks, and regional advisory communities. The firm also uses a replication thesis, which creates a pipeline from its own portfolio: successful Colombian business models are expanded into neighboring Andean countries.

MAS Equity Partners targets expansion and late-stage growth investments in medium-sized companies with high growth potential. The firm takes minority equity positions and explicitly describes its approach as 'growth capital' rather than buyout or venture capital at the seed stage. Its portfolio covers mature small- and mid-cap businesses across industrial manufacturing, healthcare services, security, and food operations that are ready for regional replication or structured expansion.

MAS Equity Partners operates as a direct private equity fund manager. The firm raises committed capital through a series of funds — Fondo FTC, Fondo MCL, and Fondo MEF III — and deploys directly into portfolio companies. It does not present itself as a fund-of-funds or an LP in other GPs' vehicles. Its value-creation model requires hands-on operational involvement, which is delivered directly to each portfolio company through a proprietary 'Building Blocks' methodology.

The firm does not publish a formal exclusion list. The portfolio reveals a preference for tangible, middle-market operating businesses — industrial manufacturing, healthcare services, real estate development, security, logistics, and food — with no disclosed exposure to early-stage technology, pure-play software, fintech, or biotech. Its investment principles emphasize 'innovative business models with sustainable competitive advantages,' but the implementation has been concentrated in traditional industries where regional replication is feasible.

The firm does not attribute its capital to a single family, founder liquidity event, or identified wealth origin. MAS Equity Partners presents itself as an independent private equity fund manager — not a single-family office — raising capital for its fund vintages from external limited partners. The principals' personal wealth origins are not publicly disclosed.

The firm lists nine exited investments on its website, spanning food production, chemicals distribution, transport and logistics, high-complexity hospitals, restaurant and entertainment, health and wellness, financial services, agroindustry, and oil and gas services. Third-party validation includes the 2018 sale of Promotora Medica Las Americas — recognized by BTG Pactual — and Grupo IGA, which was named 'Top Deal in Latin America' by LAVCA in March 2018. ColCapital has repeatedly recognized the firm's exits, with awards for Bodytech, OPL Carga, Rocsa Colombia, and Grupo IGA.